Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ARWR - Big jump today. Found this on another board, related the jump?
Gilead Sciences, Inc. (NASDAQ:GILD) Looks Forward To Acquiring Arrowhead Research Corp (NASDAQ:ARWR) 0
BY THOMAS COPELAND ON JANUARY 1, 2015 BIOPHARMA
News has it that Gilead Sciences, Inc. (NASDAQ:GILD) is looking forward to sealing an acquisition deal with Arrowhead Research Corp (NASDQ:ARWR). The company bought a small cap of the latter’s stock, and now it wants to acquire the whole company. According to the news, the healthcare giant wants to acquire Arrowhead for its hepatitis B drugs. The pipeline of Arrowhead is very strong, as it contains ARC-520 drug.
Arrowhead Research Corp (NASDAQ:ARWR) is based in California. The company has a number of important drugs in its pipeline; some of them being the experimental ones. The ARC-520 drug of Arrowhead is being tested for the cure of hepatitis B. Another significant drug that Arrowhead is testing is an anti-obesity one.
Gilead Sciences, Inc. (NASDAQ:GILD) recently bought some stocks in Arrowhead, causing the share price of Arrowhead to go up by 14.5 percent. The average trading volume for 30 day period was recorded to be at 2.23 million; however, the stocks volume reached 11.7 million as soon as Gilead bought the shares.
The stocks of Arrowhead plummeted in the last few months, due to a rough period that the company was going through. The company released a research report on the phase 2 trial study of one of its hepatitis drugs: the results of the study were not very favorable, causing the investors to trade their shares. The results were even weaker than what the company and the analysts were expecting. Some of the investors sought help from law firms and filed suits against the company, alleging that Arrowhead did not reveal the full information about the drug, and thus tricked the investors into investing their money on the experimental drug.
The chief executive of Arrowhead, Christopher Anzalone, on the other hand, is very confident about the company, especially the technology that it is developing in its test units in Madison. According to Christopher, the company has investment in research and development, which is not a bad choice. He further stated that the investments will pay off very soon.
That said, Arrowhead can only afford to lose a few competitions, for the situation in healthcare industry is quite tense at the moment. It is important to mention here that ARC-520 is an RNA interference drug. Gilead Sciences, Inc. (NASDAQ:GILD) has 3 products in its pipeline; however, none of them is an RNA interference drug. The only other company that is developing and RNA interference drug for hepatitis B is Alnylam Pharmaceuticals (NASDAQ:ALNY)
Gilead Sciences, Inc. (NASDAQ:GILD) currently has $6.2 billion cash lying around, so it can surely afford Arrowhead. The acquisition will not only improve its pipeline for hepatitis B drugs but it will also make the company’s position a dominant one in the market. Since the market for hepatitis drugs is quite big- around 5 percent of the total population suffers from it- Gilead Sciences, Inc. (NASDAQ:GILD) will be making a positive decision from the point of view of sales, profits and revenues.
EXAS looking to gap up nicely.
Opps UNIS 4.12. A bit too quick on the trigger.
Out my UNIS @ 3.79
Picked up a butt load of EAC here at 26.65 740 shares
Picked up some PIKE yesterday at 12.89 on the Magic Box confirmation. Also picked up some UNIS at 3.43....Aggie
NQ 9.04
nq 8.97 lol
NQ 8.77
Picked up 500 NQ @ 8.53. Looking for a post earnings bounce.
Picked up 500 NQ @ 8.53. Looking for a post earnings bounce.
Picked up 500 NQ @ 8.53 for the bounce. Earnings were not bad and expect the drop to be shortterm.
Out SFY for at 13.30 for a small loss. Got bored with this one. Like watching paint dry....
Out EAC at 25.00 today from 20.90 for 410 shares. I put this GTC order in when I purchased and it hit before I could reset. EAC going to 30.00....Aggie
Stopped by to see what all the chatter is about. No volume here.
Is this CEO Jacob DiMartino the same Jacob DiMartino from Choice One Solutions???? Do your research. Good luck here guys.
EAC now 23.95. Thats +$3.00
EAC gapped +2.50 at open on yesterdays earnings report.
Sorry Multiple post
Thanks, but no thanks. Dont like the volume. Dont like OTCBB. Dont like the chart.
EAC 23.50 in early trading. Looking for a huge gap up at open.
NQ now at 9.58 and HOD. SFY now at 13.51 and also HOD. EAC moving as well.
EAC now at 21.15 and looking for more. NQ and SFY (my other two holdings) up nicely today also.
Picked up 410 shares of EAC on this dip @ 20.90.
NQ now 9.40
NQ now back to 9.30. Earnings on 5/15.
NQ now back to 9.30. Earnings on 5/15.
Back in NQ today for 1000 shares at 8.87. Looking for a run up into earnings on 5/15...
Quick hitter on FLML today. In 1000 shares @ 4.67 and out @ 4.90.
Could someone explain RTF for a non-biotech trader?
FLML $4.70 Disclosed that they got a RTF on another mystery submission. May be a chance to load up on the dip...
Thanks Aggie.
In SNTS yesterday at 3:45 @ 18.89. Out AH @ 21.00 on a Sheff call.
05/06/2013
SNTS
SANTARUS INC
Buy
500.0000
$18.89
$9,451.00
05/06/2013
SNTS
SANTARUS INC
Sell
– 500.0000
$21.00
– $10,492.76
Out the remainder of my NQ 9.25 from 7.97. Will look to reenter on any dip below 9.00.
Out 1000 NQ 8.32 to 8.90. Still holding 935 shares from 7.97.
Picked up 500 SFY at 13.42 on Magic Box confirmation
Put KCAP 10.12 to 10.70 for 500 shares. Magic Box scan.
SFY trying to confirm on the magic box scan. On high alert.
Out KLIC 10.70 to 11.00 for 500 shares. Magic box scan.
Out WNC 9.00 to 9.40 for 1000 shares. Magic Box scan.
TNGO and FNSR on watch for Magic box confirmation.
CCME - not sure if this is posted. Found on Burp's board.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85604020
This was on Burp's page. Starr won their ruling in Hong Kong.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85604020